Evidence map›Paper›PMID 41459813›Full record

GuidelineJapanese journal of clinical oncology2026

JPOS/JASCC clinical guidelines for psychological distress in adult cancer patients: a summary of recommendations.

Daisuke Fujisawa, Eisho Yoshikawa, Maiko Fujimori, Sachiko Arai, Makoto Kobayakawa, Akiko Kurata, Ayako Kayano, Kanako Ichikura, Yuri Igarashi, Hiroyuki Otani and 16 more

Abstract readPractice Guideline
In one paragraph

Guideline in Japanese journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Daisuke FujisawaDivision of Quality Assurance Programs, National Cancer Center Institute for Cancer Control, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-1913-6955
Eisho YoshikawaDepartment of Medical Psychology, Nippon Medical School, 1-7-1, Sakaiminami-cho, Musashino-shi, Tokyo 180-0023, Japan.
Maiko FujimoriDivision of Survivorship Research, National Cancer Center Institute for Cancer Control, Tokyo 104-0045, Japan.ORCID 0000-0003-1639-3390
Sachiko AraiPharmacy Division, Yokohama City University Hospital, Yokohama 236-0004, Japan.
Makoto KobayakawaDepartment of Psychiatry, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima 730-8619, Japan.
Akiko KurataDepartment of Psychiatry, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Ayako KayanoDepartment of Psycho-Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Kanako IchikuraDepartment of Health Science, Kitasato University School of Allied Health Sciences, Sagamihara 252-0373, Japan.
Yuri IgarashiDepartment of Psychological Counseling, Faculty of Humanities, Tokyo Kasei University, Tokyo 173-8602, Japan.
Hiroyuki OtaniDepartment of Palliative Care Team, and Palliative and Supportive Care, St. Mary's Hospital, Kurume City 830-8543, Japan.
Yuko YanaiDepartment of Psycho-Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Tomoko BabaNursing Department, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
Yoshiro OkajimaDepartment of Psychiatry, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
Akiko AbeDepartment of Palliative Medicine, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Yu UnenoDepartment of Palliative Medicine, Kyoto University Hospital, Kyoto 606-8507, Japan.ORCID 0000-0002-0322-8815
Masako OkamuraDivision of Survivorship Research, National Cancer Center Institute for Cancer Control, Tokyo 104-0045, Japan.
Yoshihisa MatsumotoDepartment of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.ORCID 0000-0003-3112-4818
Kurumi AsaumiDepartment of Nursing, School of Health Sciences, Tokyo University of Technology, Tokyo 144-8535, Japan.
Kazuho HisamuraDepartment of Epidemiology and Public Health, School of Medicine, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Kanae MominoDepartment of Nursing, Nagoya City University Graduate School of Nursing, Nagoya 467-8601, Japan.
Emi TakeuchiDivision of Quality Assurance Programs, National Cancer Center Institute for Cancer Control, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.ORCID 0000-0003-1632-6876
Atsushi SatoDepartment of Medical Oncology, Hirosaki University School of Medicine, Hirosaki 036-8562, Japan.
Noriko TamuraDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan.
Akiko Imai(Citizen representative: this author does not have an affiliation).
Ryoichi SadahiroDepartment of Psycho-Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.ORCID 0000-0003-2315-2771
Toru OkuyamaDepartment of Psychiatry / Palliative Care Center, Nagoya City University West Medical Center, Nagoya 462-0057, Japan.ORCID 0000-0003-0504-6406

Funding

Grant-in-aid by the Ministry of Health Labor and Welfare Japan 202208011C
6 · The paper itself

Abstract

objectivesThis article aims to describe the newly developed Japanese practice guidelines for psychological distress of adult individuals with cancer who have elevated levels of psychological distress.

methodsWe conducted systematic reviews and Delphi consensus rounds to determine the levels of certainty of evidence and strength of recommendation.

resultsIn our proposed flow of care, all individuals with cancer should initially be provided with general support, comprising supportive communication, detection of psychological distress, attendance to their needs, and differentiating physical conditions that mimic psychological distress. If a patient still has significant psychological distress despite such support, more specific care for psychological distress should be considered. Collaborative care has strong evidence base and is strongly recommended. Evidence for psychotherapy for psychological distress and fear of cancer recurrence is moderate to strong, however, recommendations for these interventions were weakened because of the heterogeneity of interventions and lack of formal training system. Evidence of pharmacotherapy was weak. Thus, anxiolytics are weakly recommended only for short term and should be accompanied with psychosocial support. Antidepressants are weakly recommended when a patient is diagnosed with depression. Early specialized palliative care, care for caregivers and peer support are not recommended as a sole means to alleviate psychological distress, due to the scarce supporting evidence. Provision of these interventions is not hindered when they aim to improve the outcomes other than psychological distress, such as quality of life, symptom burden and self-efficacy. DISCUSSION: New practice guidelines for psychological distress of adult individuals with cancer have been developed.

Indexed as

NeoplasmsPractice Guidelines as TopicPsychological DistressStress, PsychologicalAdultHumansQuality of Lifeanxietycancercaredepressionsupport

Identifiers

PMID41459813
PMCPMC13016891

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.